Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Absci Corporation (ABSI) Balance Sheet

As of 2026-06-30 (10-Q), Absci Corporation (ABSI) reported total assets of $268.9M, total liabilities of $22.8M and shareholders' equity of $246.1M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $107.9M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ABSIAbsci CorporationFollow ABSI — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
1.6B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
12 Nov, in 19 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents252.660.072.441.220.0107.9
Short-term investments0.0——71.2124.393.3
Receivables——2.20.0——
Current assets273.1186.9120.6133.8149.6208.3
Total assets426.2321.0217.3213.6216.3268.9
Current liabilities33.930.329.628.722.819.6
Long-term debt1.18.04.71.30.0—
Total liabilities60.146.641.134.526.822.8
Shareholders' equity366.1274.4176.2179.1189.4246.1

USD millions · SEC XBRL

Absci Corporation — questions

How much cash does Absci Corporation have?
$107.9M in cash and cash equivalents as of 2026-06-30.
What are Absci Corporation's total assets?
$268.9M as of 2026-06-30.
What is Absci Corporation's shareholders' equity?
$246.1M as of 2026-06-30.

Every figure on this page comes from Absci Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.